It has been suggested that iron might play a pivotal role in the devel
opment of reperfusion-induced cellular injury through the activation o
f oxygen free radical producing reactions. The present study examined
the effects of myocardial iron overload on cardiac vulnerability to is
chemia and reperfusion. Moreover, the effect of the iron chelator defe
roxamine in reversing ischemia-reperfusion injury was studied. Animals
were treated with iron dextran solution (i.m. injection, 25 mg every
third day during a 5 week period). The control group received the same
treatment without iron. Isolated rat hearts were perfused at constant
flow (11 ml/min) and subjected to a 15 minute period of global normot
hermic ischemia followed by reperfusion for 15 minutes. The effects of
iron overload were investigated using functional and biochemical para
meters, as well as ultrastructural characteristics of the ischemic-rep
erfused myocardium compared with placebo values. The results suggest t
hat (a) a significant iron overload was obtained in plasma and hepatic
and cardiac tissues (x 2.5, x 16, and x 8, respectively) after chroni
c intramuscular administration of iron dextran (25 mg); (b) during nor
moxia, iron overload was associated with a slight reduction in cardiac
function and an increase in lactate dehydrogenase (LDH) release (x 1.
5); (c) upon reperfusion, functional recovery was similar whether the
heart had been subjected to iron overload or not. However, in the cont
rol group left ventricular end-diastolic pressure remained higher than
in preischemic conditions, an effect that was not observed in the iro
n-overloaded group. Moreover, LDH release was markedly increased in th
e iron-loaded group ( x 4.2); (d) iron overload was associated with a
significant worsening of the structural alterations observed during re
perfusion, particularly at the mitochondrial and sarcomere level; (e)
after.15 minutes of reperfusion, the activity of the anti-free-radical
enzyme, glutathione peroxidase (GPX), was significantly reduced in ir
on-overloaded hearts, whereas catalase activity was increased; (e) the
overall modifications observed in the presence of iron overload were
prevented by deferoxamine. In conclusion, this study underlines the po
ssible role of cardiac iron in the development of injury associated wi
th ischemia and reperfusion, and the possible importance of the use of
an iron-chelating agent in antiischemic therapy.